Skip to main content
. 2019 May 22;21(4):66. doi: 10.1208/s12248-019-0332-z

Fig. 3.

Fig. 3

PF-06671008-induced tumor T cell proliferation in mice bearing HCT-116 tumors with human PBMC engraftment. Number of CD3+ cells/mg of the tumor (with standard deviations) is plotted against time following IV administration of control and PF-06671008 at 10 μg/kg, 50 μg/kg, and 500 μg/kg